Europe — EMA
Ovamex (Ganirelix)
Ganirelix, the active ingredient in Ovamex, is a gonadotropin-releasing hormone antagonist presented as a solution for subcutaneous injection use.
Request sourcing
What is Ganirelix?
Ganirelix, the active ingredient in Ovamex, is a gonadotropin-releasing hormone antagonist presented as a solution for subcutaneous injection use. It is used in controlled ovarian stimulation protocols to prevent premature luteinizing hormone surges in women undergoing assisted reproductive technology procedures. GNH USA supplies Ovamex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, fertility clinics and IVF centres worldwide.
GNH USA supplies Ovamex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, fertility clinics and IVF centres worldwide.
What is Ganirelix used for?
Ganirelix is employed in assisted reproductive technology to regulate the hormonal pathway of ovarian stimulation.
- In vitro fertilisation (IVF): It makes the tim‑ and tim‑ tim tim .... - C ....
What are the side effects of Ganirelix?
Common t ...
What precautions apply to Ganirelix?
...
